RecruitingPhase 1NCT07310420
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Sponsor: TerSera Therapeutics LLC
Hot Springs, AR · +25 more sites
3 recruiting breast cancer studies with a site in Hot Springs, AR.
Sponsor: TerSera Therapeutics LLC
Hot Springs, AR · +25 more sites
Sponsor: Eli Lilly and Company
Hot Springs, AR · Springdale, AR · +127 more sites
Sponsor: Guardant Health, Inc.
Hot Springs, AR · +32 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.